Strongyloidiasis: The Harada-Mori test revisited

Clinical Microbiology and Infection

Volumn 5, Issue 6, 1999, Pages 374-376

  Martín Rabadán, Pablo ^a   Muñoz, Patricia ^a   Palomo, Jesús ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; IVERMECTIN; TIABENDAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FECES ANALYSIS; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 17344374411     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00157.x     Document Type: Article

References (17)

1. Stürchler D. Endemic areas of tropical infections. Stuttgart: Hans Huber Publishers, 1988; 260-2.
2. Grove DI. Strongyloidiasis. In Warren KS, Mahmoud AF, eds. Tropical and geographical medicine. New York: MacGraw-Hill, 1990: 393-9.
3. German JC, Flores JH, Chiesura G, et al. Estrongiloidiasis fatal en paciente inmunodeprimido pos-trasplante renal. Rev Hosp Clin Fac Med Sao Paulo 1992; 47: 31-3.
4. Celedon JC, Mathur-Wagh AU, Fox J, Garcia R, Wiest PM. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Medicine (Baltimore) 1994; 73: 256-63.
5. Lessnau K-D, Can S, Talavera W. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and review of the literature. Chest 1993; 104: 119-22.
6. Pelletier LL. Chronic strongyloidiasis in World War II Far East ex-prisoners of war. Am J Trop Med Hyg 1984; 33: 55-61.
7. Grove DI. Strongyloidiasis in Allied ex-prisoners of war in Southeast Asia. Br Med J 1980; 280: 598-601.
8. DeVault GA, King JW, Rohr MS, Landreneau MD, Brown III ST, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12: 653-71.
9. Harada Y, Mori O. A new method for culturing hookworm. Yonago Acta Med 1955; 1: 177-9.
10. Garcia LS, Bruckner DA. Additional techniques for stool examination. Diagnostic medical parasitology. Washington DC: American Association for Microbiology, 1997: 652-61.
11. Grove DI. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg 1982; 76: 114-18.
12. Naquira C, Jimenez G, Guerra JG, et al. Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg 1989; 40: 304-9.
13. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88: 344-5.
14. Torres JR, Isturiz R, Murillo J, Guzmán M, Contreras R. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993; 17: 900-2.
15. Gann PH, Neva FA, Gam AA. A randomized trial of single-and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169: 107.
16. Schad GA. Cyclosporin may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 1986; 153: 178.
17. Nolan TJ, Schad GA. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 1996; 62: 1038.